# REGN (Regeneron Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Regeneron Pharmaceuticals, Inc. reported $16.90B in revenue and net income of $4.82B for the trailing twelve months ended September 30, 2026 (up 36.3% year over year), with a 28.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/REGN
- Markdown: https://convexityos.com/fundamentals/REGN.md
- SEC CIK: 0000872589
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $16.90B | +36.3% YoY |
| Operating Income | TTM | $4.86B | 28.8% margin |
| Net Income | TTM | $4.82B | 28.5% net margin |
| Diluted EPS | TTM | $45.62 | Split-adjusted |
| Free Cash Flow | TTM | $3.83B | 22.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $9.30B | Total debt: $2.71B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $14.34B | $14.20B | $13.12B | $12.17B | $16.07B | $8.50B | $6.56B | $5.15B | $5.87B | $4.86B |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $402.8M | $237.5M | $202.5M | $194.6M |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | $6.15B | $4.91B | $5.67B | $4.67B |
| Research & Development | $5.85B | $5.13B | $4.44B | $3.59B | $2.86B | $2.65B | $2.45B | $1.47B | $2.08B | $2.05B |
| Selling, General & Admin | $2.70B | $2.95B | $2.63B | $2.12B | $1.82B | $1.35B | $1.34B | $1.13B | $1.32B | $1.18B |
| **Operating Income** | $3.58B | $3.99B | $4.05B | $4.74B | $8.95B | $3.58B | $2.21B | $2.53B | $2.08B | $1.33B |
| **EBITDA** | $4.12B | $4.47B | $4.47B | $5.08B | $9.23B | $3.81B | $2.42B | $2.68B | $2.23B | $1.44B |
| Interest Expense | $43.80M | $55.20M | $73.00M | $59.40M | $57.30M | $56.90M | $30.20M | $28.20M | $25.10M | $7.20M |
| Income Before Tax | $5.23B | $4.78B | $4.20B | $4.86B | $9.33B | $3.81B | $2.43B | $2.55B | $2.08B | $1.33B |
| Income Tax Expense | $725.8M | $367.3M | $245.7M | $520.4M | $1.25B | $297.2M | $313.3M | $109.1M | $880.0M | $434.3M |
| **Net Income** | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B | $3.51B | $2.12B | $2.44B | $1.20B | $895.5M |
| Basic EPS | $43.07 | $40.90 | $37.05 | $40.51 | $76.40 | $32.65 | $19.38 | $22.65 | $11.27 | $8.55 |
| **Diluted EPS** | $41.48 | $38.34 | $34.77 | $38.22 | $71.97 | $30.52 | $18.46 | $21.29 | $10.34 | $7.70 |
| Basic Shares Outstanding | 104.6M | 107.9M | 106.7M | 107.1M | 105.7M | 107.6M | 109.2M | 107.9M | 106.3M | 104.7M |
| Diluted Shares Outstanding | 108.6M | 115.1M | 113.7M | 113.5M | 112.2M | 115.1M | 114.6M | 114.8M | 115.9M | 116.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $5.12B | $4.29B | $3.61B | $3.88B | $3.75B | $3.68B | $3.03B | $3.79B |
| Research & Development | $1.79B | $1.63B | $1.54B | $1.63B | $1.48B | $1.42B | $1.33B | $1.41B |
| Selling, General & Admin | $677.8M | $662.1M | $647.7M | $775.0M | $657.8M | $634.2M | $633.0M | $792.2M |
| **Operating Income** | $2.05B | $1.29B | $642.9M | $879.9M | $1.03B | $1.08B | $591.7M | $990.2M |
| **EBITDA** | $2.17B | $1.42B | $766.1M | $1.02B | $1.16B | $1.21B | $718.6M | $1.12B |
| Interest Expense | $10.60M | $11.00M | $12.90M | $12.20M | $19.30M | $3.60M | $8.70M | $10.50M |
| Income Before Tax | $2.28B | $1.53B | $831.2M | $1.04B | $1.76B | $1.52B | $905.0M | $958.1M |
| Income Tax Expense | $335.4M | $230.9M | $104.0M | $199.1M | $303.3M | $127.1M | $96.30M | $40.40M |
| **Net Income** | $1.95B | $1.30B | $727.2M | $844.6M | $1.46B | $1.39B | $808.7M | $917.7M |
| Basic EPS | $19.16 | $12.62 | $6.99 | -- | $14.09 | $13.24 | $7.58 | -- |
| **Diluted EPS** | $18.45 | $12.23 | $6.75 | -- | $13.62 | $12.81 | $7.27 | -- |
| Basic Shares Outstanding | 101.7M | 102.8M | 104.0M | -- | 103.6M | 105.1M | 106.7M | -- |
| Diluted Shares Outstanding | 105.6M | 106.0M | 107.7M | -- | 107.2M | 108.6M | 111.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.12B | $2.49B | $2.73B | $3.11B | $2.89B | $2.19B | $1.62B | $1.47B | $812.7M | $535.2M |
| Short-Term Investments | $5.49B | $6.52B | $8.11B | $4.64B | $2.81B | $1.39B | $1.60B | $1.34B | $596.8M | $503.5M |
| **Cash & Short-Term Investments** | $8.61B | $9.01B | $10.84B | $7.74B | $5.69B | $3.59B | $3.21B | $2.81B | $1.41B | $1.04B |
| Accounts Receivable, Net | $5.74B | $6.21B | $5.67B | $5.33B | $6.04B | $4.11B | $2.10B | $1.72B | $1.54B | $1.34B |
| Inventory | $3.20B | $3.09B | $2.58B | $2.40B | $1.95B | $1.92B | $1.42B | $1.15B | $726.1M | $399.4M |
| **Total Current Assets** | $18.02B | $18.66B | $19.48B | $15.88B | $14.01B | $9.78B | $7.69B | $6.45B | $4.33B | $3.18B |
| Property, Plant & Equipment, Net | $5.12B | $4.60B | $4.15B | $3.76B | $3.48B | $3.22B | $2.89B | $2.58B | $2.36B | $2.08B |
| Intangible Assets | $1.26B | $1.15B | $1.04B | $915.5M | $6.70M | -- | -- | -- | -- | -- |
| Long-Term Investments | $10.26B | $8.90B | $5.40B | $6.59B | $6.84B | $3.14B | $3.26B | $1.75B | $1.49B | $864.3M |
| Other Non-Current Assets | $1.82B | $1.14B | $444.1M | $336.4M | $216.1M | $168.1M | $144.7M | $127.4M | $77.90M | $20.29M |
| **Total Non-Current Assets** | $22.54B | $19.10B | $13.60B | $13.33B | $11.42B | $7.38B | $7.12B | $5.29B | $4.43B | $3.79B |
| **Total Assets** | $40.56B | $37.76B | $33.08B | $29.21B | $25.43B | $17.16B | $14.81B | $11.73B | $8.76B | $6.97B |
| Accounts Payable | $939.0M | $789.5M | $606.6M | $589.2M | $564.0M | $475.5M | $418.1M | $218.2M | $178.2M | $135.0M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $0 | -- | -- | -- |
| Deferred Revenue (Current) | $553.0M | $627.7M | $458.9M | $477.9M | $442.0M | $577.7M | $591.7M | $452.5M | $320.1M | $231.7M |
| Other Current Liabilities | -- | -- | -- | -- | -- | $122.4M | $85.00M | -- | $267K | $1.18M |
| **Total Current Liabilities** | $4.37B | $3.94B | $3.42B | $3.14B | $3.93B | $2.70B | $2.10B | $1.44B | $1.14B | $1.24B |
| Long-Term Debt | $1.99B | $1.98B | $1.98B | $1.98B | $1.98B | $1.98B | $0 | -- | -- | -- |
| Deferred Revenue (Non-Current) | $208.7M | $185.7M | $126.7M | $69.80M | $73.30M | $57.80M | $619.0M | $464.2M | $629.2M | $830.8M |
| Other Non-Current Liabilities | $2.02B | $1.57B | $854.1M | $638.0M | $680.2M | $687.1M | $317.7M | $361.7M | $152.0M | $100.4M |
| **Total Non-Current Liabilities** | $4.93B | $4.46B | $3.68B | $3.41B | $2.73B | $3.44B | $1.62B | $1.53B | $1.48B | $1.28B |
| **Total Liabilities** | $9.30B | $8.41B | $7.11B | $6.55B | $6.67B | $6.14B | $3.72B | $2.98B | $2.62B | $2.52B |
| **Total Debt (incl. Leases)** | $2.97B | $2.94B | $2.79B | $2.77B | $2.70B | $2.70B | $737.5M | -- | -- | -- |
| Retained Earnings | $35.80B | $31.67B | $27.26B | $23.31B | $18.97B | $10.89B | $7.38B | $5.25B | $2.95B | $1.75B |
| Accumulated Other Comp. Income | $77.50M | -$7.90M | -$80.90M | -$238.8M | -$26.20M | $29.30M | $21.10M | -$12.30M | $600K | -$12.84M |
| **Total Stockholders' Equity** | $31.26B | $29.35B | $25.97B | $22.66B | $18.77B | $11.03B | $11.09B | $8.76B | $6.14B | $4.45B |
| Total Equity | $31.26B | $29.35B | $25.97B | $22.66B | $18.77B | $11.03B | $11.09B | $8.76B | $6.14B | $4.45B |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.66B | $2.46B | $2.96B | $3.12B | $2.51B | $2.00B | $3.09B | $2.49B |
| Short-Term Investments | $5.64B | $5.54B | $5.79B | $5.49B | $5.94B | $5.47B | $5.26B | $6.52B |
| **Cash & Short-Term Investments** | $9.30B | $7.99B | $8.75B | $8.61B | $8.44B | $7.47B | $8.35B | $9.01B |
| Accounts Receivable, Net | $7.58B | $6.57B | $5.73B | $5.74B | $5.69B | $5.61B | $5.56B | $6.21B |
| Inventory | $2.89B | $3.08B | $3.10B | $3.20B | $3.25B | $3.21B | $3.19B | $3.09B |
| **Total Current Assets** | $20.80B | $18.45B | $18.21B | $18.02B | $17.98B | $16.86B | $17.57B | $18.66B |
| Property, Plant & Equipment, Net | $5.73B | $5.46B | $5.27B | $5.12B | $5.00B | $4.84B | $4.69B | $4.60B |
| Intangible Assets | $1.32B | $1.31B | $1.29B | $1.26B | $1.38B | $1.35B | $1.17B | $1.15B |
| Long-Term Investments | $9.56B | $9.83B | $9.79B | $10.26B | $10.29B | $10.06B | $9.28B | $8.90B |
| Other Non-Current Assets | $2.47B | $2.31B | $2.13B | $1.82B | $1.67B | $1.54B | $1.39B | $1.14B |
| **Total Non-Current Assets** | $23.61B | $23.28B | $22.66B | $22.54B | $22.19B | $21.36B | $19.97B | $19.10B |
| **Total Assets** | $44.41B | $41.73B | $40.87B | $40.56B | $40.17B | $38.22B | $37.55B | $37.76B |
| Accounts Payable | $1.14B | $1.16B | $1.03B | $939.0M | $903.8M | $723.9M | $705.5M | $789.5M |
| Deferred Revenue (Current) | $749.8M | $684.8M | $636.2M | $553.0M | $545.6M | $481.9M | $619.3M | $627.7M |
| **Total Current Liabilities** | $6.20B | $5.53B | $5.11B | $4.37B | $4.43B | $3.67B | $3.57B | $3.94B |
| Long-Term Debt | $1.99B | $1.99B | $1.99B | $1.99B | $1.99B | $1.99B | $1.98B | $1.98B |
| Deferred Revenue (Non-Current) | $220.2M | $220.4M | $225.1M | $208.7M | $219.2M | $206.3M | $211.8M | $185.7M |
| Other Non-Current Liabilities | $2.50B | $2.28B | $2.13B | $2.02B | $1.86B | $1.70B | $1.67B | $1.57B |
| **Total Non-Current Liabilities** | $4.70B | $4.49B | $4.34B | $4.93B | $4.79B | $4.61B | $4.59B | $4.46B |
| **Total Liabilities** | $10.91B | $10.02B | $9.45B | $9.30B | $9.21B | $8.28B | $8.16B | $8.41B |
| **Total Debt (incl. Leases)** | $2.71B | $2.71B | $2.71B | $2.97B | $2.71B | $2.71B | $2.70B | $2.94B |
| Retained Earnings | $39.47B | $37.62B | $36.42B | $35.80B | $35.05B | $33.68B | $32.38B | $31.67B |
| Accumulated Other Comp. Income | -$197.5M | -$35.80M | $11.90M | $77.50M | $69.00M | $52.50M | $29.10M | -$7.90M |
| **Total Stockholders' Equity** | $33.50B | $31.71B | $31.42B | $31.26B | $30.96B | $29.94B | $29.39B | $29.35B |
| Total Equity | $33.50B | $31.71B | $31.42B | $31.26B | $30.96B | $29.94B | $29.39B | $29.35B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $4.50B | $4.41B | $3.95B | $4.34B | $8.08B | $3.51B | $2.12B | $2.44B | $1.20B | $895.5M |
| Depreciation & Amortization | $543.7M | $482.9M | $421.0M | $341.4M | $286.2M | $235.9M | $210.3M | $148.2M | $145.5M | $104.7M |
| Stock-Based Compensation | $993.7M | $982.8M | $885.0M | $725.0M | $601.7M | $432.0M | $464.3M | $427.4M | $507.3M | $559.9M |
| Change in Receivables | $498.1M | -$554.0M | -$338.8M | $707.8M | -$1.93B | -$1.36B | -$523.7M | -$236.4M | -$362.7M | -$143.8M |
| Change in Inventory | -$275.3M | -$619.7M | -$271.7M | -$696.5M | -$494.3M | -$529.4M | -$335.5M | -$387.9M | -$314.2M | -$149.8M |
| **Operating Cash Flow** | $4.98B | $4.42B | $4.59B | $5.01B | $7.08B | $2.62B | $2.43B | $2.20B | $1.31B | $1.49B |
| Capital Expenditure | -$898.4M | -$755.9M | -$718.6M | -$590.1M | -$551.9M | -$614.6M | -$429.6M | -$383.1M | -$272.6M | -$511.9M |
| **Free Cash Flow** | $4.08B | $3.66B | $3.88B | $4.42B | $6.53B | $2.00B | $2.00B | $1.81B | $1.03B | $974.0M |
| Acquisitions, Net | -$3.30M | -$16.50M | -$54.90M | -$230.3M | $0 | -- | -- | -- | -- | -- |
| Purchases of Investments | -$10.96B | -$16.62B | -$11.65B | -$7.49B | -$7.05B | -$3.24B | -$3.20B | -$1.85B | -$1.28B | -$809.4M |
| **Investing Cash Flow** | -$629.1M | -$2.47B | -$3.19B | -$3.78B | -$5.38B | -$70.60M | -$2.03B | -$1.46B | -$1.01B | -$1.05B |
| Common Stock Issued | $635.9M | $1.47B | $1.15B | $1.52B | $1.67B | $2.58B | $211.8M | $114.5M | $240.2M | $126.7M |
| Share Repurchases | -$3.44B | -$2.60B | -$2.23B | -$2.08B | -$1.65B | -$5.85B | -$275.9M | -$4.40M | $0 | $0 |
| Dividends Paid | -$370.3M | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | -$3.72B | -$2.20B | -$1.79B | -$1.01B | -$1.01B | -$1.97B | -$252.1M | -$77.10M | -$24.40M | -$700.5M |
| **Net Change in Cash** | $634.7M | -$248.8M | -$381.6M | $221.3M | $690.8M | $577.0M | $150.1M | $655.0M | $277.5M | -$261.4M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $1.95B | $1.30B | $727.2M | $844.6M | $1.46B | $1.39B | $808.7M | $917.7M |
| Depreciation & Amortization | $121.0M | $123.7M | $123.2M | $145.0M | $136.7M | $135.1M | $126.9M | $126.4M |
| Stock-Based Compensation | $255.8M | $243.0M | $257.4M | $249.3M | $237.0M | $251.7M | $255.7M | $304.4M |
| Change in Receivables | -$1.01B | -$838.5M | $1.20M | -$51.20M | -$80.30M | -$28.20M | $657.8M | -$117.8M |
| Change in Inventory | $112.3M | -$28.20M | $26.60M | $2.10M | -$82.60M | -$42.50M | -$152.3M | -$117.7M |
| **Operating Cash Flow** | $1.78B | $813.0M | $1.08B | $1.17B | $1.62B | $1.14B | $1.05B | $1.26B |
| Capital Expenditure | -$300.2M | -$240.2M | -$230.6M | -$248.7M | -$201.4M | -$219.0M | -$229.3M | -$199.6M |
| **Free Cash Flow** | $1.48B | $572.8M | $848.3M | $922.0M | $1.42B | $925.4M | $815.8M | $1.06B |
| Purchases of Investments | -$1.53B | -$1.95B | -$2.76B | -$2.04B | -$3.52B | -$2.86B | -$2.54B | -$1.95B |
| **Investing Cash Flow** | -$288.1M | -$92.70M | -$428.9M | $220.3M | -$402.9M | -$1.09B | $647.5M | $350.6M |
| Common Stock Issued | $300.9M | $49.20M | $163.1M | $503.5M | $40.30M | $31.50M | $60.60M | $90.90M |
| Share Repurchases | -$399.7M | -$1.17B | -$794.3M | -$671.7M | -$664.0M | -$1.06B | -$1.04B | -$973.0M |
| Dividends Paid | -$95.70M | -$96.80M | -$97.80M | -$92.70M | -$91.20M | -$92.60M | -$93.80M | $0 |
| **Financing Cash Flow** | -$290.2M | -$1.22B | -$802.2M | -$780.1M | -$717.9M | -$1.13B | -$1.09B | -$1.14B |
| **Net Change in Cash** | $1.21B | -$504.6M | -$153.1M | $610.6M | $497.5M | -$1.08B | $604.0M | $477.2M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | 93.9% | 95.4% | 96.6% | 96.0% |
| **Operating Margin** | 24.9% | 28.1% | 30.9% | 38.9% | 55.7% | 42.1% | 33.7% | 49.3% | 35.4% | 27.4% |
| **Net Profit Margin** | 31.4% | 31.1% | 30.1% | 35.6% | 50.2% | 41.3% | 32.3% | 47.5% | 20.4% | 18.4% |
| Return on Equity (ROE) | 14.4% | 15.0% | 15.2% | 19.1% | 43.0% | 31.9% | 19.1% | 27.9% | 19.5% | 20.1% |
| Return on Assets (ROA) | 11.1% | 11.7% | 12.0% | 14.9% | 31.7% | 20.5% | 14.3% | 20.8% | 13.7% | 12.8% |
| Current Ratio | 4.13x | 4.73x | 5.69x | 5.06x | 3.56x | 3.63x | 3.67x | 4.47x | 3.82x | 2.56x |
| Quick Ratio | 3.39x | 3.95x | 4.94x | 4.29x | 3.07x | 2.91x | 2.99x | 3.67x | 3.18x | 2.24x |
| Debt to Equity | 0.10x | 0.10x | 0.11x | 0.12x | 0.14x | 0.24x | 0.07x | -- | -- | -- |
| **Revenue Growth (YoY)** | +1.0% | +8.3% | +7.8% | -24.3% | +89.1% | +29.6% | +27.4% | -12.4% | +20.8% | +18.4% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | +25.4% | -13.4% | +21.5% | +20.8% |
| Operating Income Growth (YoY) | -10.3% | -1.4% | -14.6% | -47.0% | +150.1% | +61.9% | -12.8% | +21.9% | +56.3% | +6.3% |
| **Net Income Growth (YoY)** | +2.1% | +11.6% | -8.9% | -46.3% | +129.9% | +66.0% | -13.4% | +104.0% | +33.8% | +40.8% |
| EPS Growth (YoY) | +5.3% | +10.4% | -8.5% | -47.0% | +134.0% | +68.5% | -14.4% | +101.0% | +31.8% | +38.6% |
| Operating Cash Flow Growth (YoY) | +12.6% | -3.8% | -8.4% | -29.2% | +170.5% | +7.7% | +10.7% | +67.9% | -12.0% | +11.7% |
| Free Cash Flow Growth (YoY) | +11.3% | -5.4% | -12.4% | -32.2% | +225.9% | +0.2% | +10.4% | +75.2% | +6.2% | +49.2% |
| 5Y Revenue / Share Growth | +73.6% | +119.2% | +157.8% | +105.7% | +227.5% | +98.3% | +114.3% | +121.9% | +279.4% | +843.5% |
| 10Y Revenue / Share Growth | +244.4% | +369.7% | +471.9% | +680.7% | +2990.3% | +1326.5% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | +31.9% | +111.1% | +63.6% | +259.3% | +793.2% | +429.0% | +476.5% | +436.1% | +42.3% | -- |
| 10Y Net Income / Share Growth | +597.8% | +1116.9% | +776.9% | +411.2% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 28.8% | 24.7% | 24.3% | 24.9% | 25.9% | 27.0% | 27.2% | 28.1% |
| **Net Profit Margin** | 28.5% | 27.9% | 29.6% | 31.4% | 32.1% | 31.4% | 31.9% | 31.1% |
| Return on Equity (ROE) | 14.4% | 13.7% | 14.1% | 14.4% | 14.8% | 14.9% | 15.3% | 15.0% |
| Return on Assets (ROA) | 10.8% | 10.4% | 10.8% | 11.1% | 11.4% | 11.7% | 12.0% | 11.7% |
| Current Ratio | 3.35x | 3.34x | 3.57x | 4.13x | 4.06x | 4.60x | 4.93x | 4.73x |
| Quick Ratio | 2.89x | 2.78x | 2.96x | 3.39x | 3.33x | 3.72x | 4.03x | 3.95x |
| Debt to Equity | 0.08x | 0.09x | 0.09x | 0.10x | 0.09x | 0.09x | 0.09x | 0.10x |
| **Revenue Growth (YoY)** | +36.3% | +16.7% | +19.0% | +2.5% | +0.9% | +3.6% | -3.7% | +10.3% |
| Operating Income Growth (YoY) | +99.5% | +19.8% | +8.7% | -11.1% | -12.9% | +0.9% | -21.3% | +1.8% |
| **Net Income Growth (YoY)** | +33.5% | -6.8% | -10.1% | -8.0% | +8.9% | -2.8% | +12.0% | -20.9% |
| EPS Growth (YoY) | +36.0% | -4.7% | -7.8% | -- | +13.6% | -0.1% | +13.1% | -- |
| Operating Cash Flow Growth (YoY) | +10.2% | -29.0% | +3.2% | -7.3% | +25.4% | +223.3% | -30.9% | +15.9% |
| Free Cash Flow Growth (YoY) | +4.6% | -38.1% | +4.0% | -13.3% | +35.1% | +433.4% | -40.8% | +26.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
